Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Kymriah cells dispersion for infusion {equilateral_black_triangle}

Active Ingredient:
tisagenlecleucel
Company:  
Novartis Pharmaceuticals UK Ltd See contact details
ATC code: 
L01XX71
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Live Chat HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Kymriah HCP training

{healthcare_pro_orange} For Healthcare Professionals
Training on risks and management of CRS and neurological events, patient education and adverse event reporting
{pdf_link}

Kymriah Patient Alert Card

{healthcare_pro_orange} For Healthcare Professionals
Alert card to be carried by patients
{pdf_link}

Kymriah Patient Educational Leaflet

Information for patients and caregivers
{pdf_link}

Kymriah Pharmacy Training

{healthcare_pro_orange} For Healthcare Professionals
Pharmacy / Cell Lab / Infusion centre training material on steps for reception, storage, handling and preparation for infusion

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Novartis Pharmaceuticals UK Ltd
Company image
Address
2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ
Telephone
+44 (0)1276 692 255
Medical Information Direct Line
+44 (0)1276 698 370
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)845 741 9442
E-mail
[email protected]